20-34534689-C-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_014183.4(DYNLRB1):c.141C>A(p.His47Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000131 in 1,605,622 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_014183.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DYNLRB1 | NM_014183.4 | c.141C>A | p.His47Gln | missense_variant | 3/4 | ENST00000357156.7 | NP_054902.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DYNLRB1 | ENST00000357156.7 | c.141C>A | p.His47Gln | missense_variant | 3/4 | 1 | NM_014183.4 | ENSP00000349679.2 | ||
ENSG00000289720 | ENST00000696979.1 | n.*248C>A | non_coding_transcript_exon_variant | 27/28 | ENSP00000513014.1 | |||||
ENSG00000289720 | ENST00000696979.1 | n.*248C>A | 3_prime_UTR_variant | 27/28 | ENSP00000513014.1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152216Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1453406Hom.: 0 Cov.: 31 AF XY: 0.00000969 AC XY: 7AN XY: 722408
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152216Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74366
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 29, 2024 | The c.141C>A (p.H47Q) alteration is located in exon 3 (coding exon 3) of the DYNLRB1 gene. This alteration results from a C to A substitution at nucleotide position 141, causing the histidine (H) at amino acid position 47 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at